Sökning: "Bacteriocin"

Visar resultat 6 - 8 av 8 avhandlingar innehållade ordet Bacteriocin.

  1. 6. Development of novel tools for prevention and diagnosis of Porphyromonas gingivalis infection and periodontitis

    Författare :Sravya Sowdamini Nakka; Örebro universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Biomedicin; Biomedicine;

    Sammanfattning : Periodontitis is a chronic infectious disease causing inflammation and destruction of tooth-supporting structures eventually leading to tooth loss. Periodontitis is induced by different subgingival microorganisms in combination with an excessive and dysregulated immune-inflammatory response against this microbial challenge. LÄS MER

  3. 7. Development of novel tools for prevention and diagnosis of Porphyromonas gingivalis infection and periodontitis

    Författare :Sravya Sowdamini Nakka; Torbjörn Bengtsson; Hazem Khalaf; Fariba Nayeri; Johanna Lönn; Tülay Lindberg; Örebro universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Periodontitis; Porphyromonas gingivalis; anti-P. gingivalis antibodies; surface plasmon resonance; PLNC8 αβ; proliferation; growth factors.; Biomedicin; Biomedicine;

    Sammanfattning : Periodontitis is a chronic inflammatory disease caused by exaggerated host immune responses to dysregulated microbiota in dental biofilms leading to degradation of tissues and alveolar bone loss. Porphyromonas gingivalis is a major periodontal pathogen and expresses several potent virulence factors. LÄS MER

  4. 8. Peptide-Liposome Model Systems for Triggered Release

    Författare :Camilla Skyttner; Daniel Aili; Karin Enander; Fredrik Höök; Linköpings universitet; []
    Nyckelord :NATURVETENSKAP; NATURAL SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; NATURVETENSKAP; NATURAL SCIENCES;

    Sammanfattning : Liposomes are widely used in drug delivery to improve drug efficacy and to reduce side effects. For liposome-encapsulated drugs to become bioavailable and provide a therapeutic effect they must be released, which typically is a slow process that primarily relies on passive diffusion, liposome rupture or endocytotic uptake. LÄS MER